BLFS
Biolife Solutions IncCompany with tickers: BLFS
CIK
834365
CUSIP
09062W204
Shares Outstanding
48,857,415
13F Activity (30d)
148 filings
148 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $10,004,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Gross Profit | $17,496,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Expenses | — | ||||
| Research & Development | $2,650,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $27,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $1,186,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $0.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $0.02 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |